Prophylactics of Erectile Dysfunction in Patients with Metabolic Syndrome
For prophylactics of erectile dysfunction in patients with metabolic syndrome, all unfavorable life-style factors should be excluded and all metabolic disturbances should be corrected. This will reduce the severity and stabilize the course of metabolic syndrome. Administration of special drugs is re...
Gespeichert in:
| Veröffentlicht in: | Bulletin of experimental biology and medicine 2009-08, Vol.148 (2), p.318-321 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 321 |
|---|---|
| container_issue | 2 |
| container_start_page | 318 |
| container_title | Bulletin of experimental biology and medicine |
| container_volume | 148 |
| creator | Gamidov, S. I Mazo, E. B Gasanov, R. V Sotnikova, E. M |
| description | For prophylactics of erectile dysfunction in patients with metabolic syndrome, all unfavorable life-style factors should be excluded and all metabolic disturbances should be corrected. This will reduce the severity and stabilize the course of metabolic syndrome. Administration of special drugs is required for prevention of erection disturbances. |
| doi_str_mv | 10.1007/s10517-009-0690-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733703454</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1921532081</sourcerecordid><originalsourceid>FETCH-LOGICAL-c377t-916f6cb32a7f96ce2d3b90ca9e1a5124062621cfe41da797317f013b81b634173</originalsourceid><addsrcrecordid>eNp9kUtLxTAQhYMoen38ADdaXOiqOpO0SbMU36AoqOuQ5iZa6W2uSYvcf28u9QEuXM0M-c4ZMoeQXYRjBBAnEaFEkQPIHLiEHFbIBEvB8opSXCUTSFBeVFW1QTZjfFuOwHGdbFAAKlhZTcjNQ_Dz10WrTd-YmHmXXQSb-tZm54vohi71vsuaLnvQfWO7PmYfTf-a3dle175tTPa46KbBz-w2WXO6jXbnq26R58uLp7Pr_Pb-6ubs9DY3TIg-l8gdNzWjWjjJjaVTVkswWlrUJdICOOUUjbMFTrWQgqFwgKyusOasQMG2yNHoOw_-fbCxV7MmGtu2urN-iEowJoAVZZHIw39JirTiheQJPPgDvvkhdOkXiWGFLKWkCcIRMsHHGKxT89DMdFgoBLWMQ41xqBSHWsahIGn2voyHemanP4rv-yeAjkBMT92LDb-b_3PdH0VOe6VfQhPV8yNNRwIUWDJZsk-UKZyI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>213495992</pqid></control><display><type>article</type><title>Prophylactics of Erectile Dysfunction in Patients with Metabolic Syndrome</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Gamidov, S. I ; Mazo, E. B ; Gasanov, R. V ; Sotnikova, E. M</creator><creatorcontrib>Gamidov, S. I ; Mazo, E. B ; Gasanov, R. V ; Sotnikova, E. M</creatorcontrib><description>For prophylactics of erectile dysfunction in patients with metabolic syndrome, all unfavorable life-style factors should be excluded and all metabolic disturbances should be corrected. This will reduce the severity and stabilize the course of metabolic syndrome. Administration of special drugs is required for prevention of erection disturbances.</description><identifier>ISSN: 0007-4888</identifier><identifier>EISSN: 1573-8221</identifier><identifier>DOI: 10.1007/s10517-009-0690-0</identifier><identifier>PMID: 20027358</identifier><identifier>CODEN: BEXBAN</identifier><language>eng</language><publisher>Boston: Boston : Springer US</publisher><subject>Adult ; Aged ; Antibodies - therapeutic use ; Antihypertensive Agents - therapeutic use ; Arginine - analogs & derivatives ; Arginine - metabolism ; asymmetrical dimethylarginine ; Biomedical and Life Sciences ; Biomedicine ; Cell Biology ; endothelial function ; erectile dysfunction ; Erectile Dysfunction - metabolism ; Erectile Dysfunction - pathology ; Erectile Dysfunction - prevention & control ; Humans ; Hypoglycemic Agents - therapeutic use ; Hypolipidemic Agents - therapeutic use ; Internal Medicine ; Laboratory Medicine ; Male ; metabolic syndrome ; Metabolic Syndrome - drug therapy ; Metabolic Syndrome - metabolism ; Metabolic Syndrome - physiopathology ; Middle Aged ; Pathology ; Ultralow Doses</subject><ispartof>Bulletin of experimental biology and medicine, 2009-08, Vol.148 (2), p.318-321</ispartof><rights>Springer Science+Business Media, Inc. 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c377t-916f6cb32a7f96ce2d3b90ca9e1a5124062621cfe41da797317f013b81b634173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10517-009-0690-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10517-009-0690-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20027358$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gamidov, S. I</creatorcontrib><creatorcontrib>Mazo, E. B</creatorcontrib><creatorcontrib>Gasanov, R. V</creatorcontrib><creatorcontrib>Sotnikova, E. M</creatorcontrib><title>Prophylactics of Erectile Dysfunction in Patients with Metabolic Syndrome</title><title>Bulletin of experimental biology and medicine</title><addtitle>Bull Exp Biol Med</addtitle><addtitle>Bull Exp Biol Med</addtitle><description>For prophylactics of erectile dysfunction in patients with metabolic syndrome, all unfavorable life-style factors should be excluded and all metabolic disturbances should be corrected. This will reduce the severity and stabilize the course of metabolic syndrome. Administration of special drugs is required for prevention of erection disturbances.</description><subject>Adult</subject><subject>Aged</subject><subject>Antibodies - therapeutic use</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Arginine - analogs & derivatives</subject><subject>Arginine - metabolism</subject><subject>asymmetrical dimethylarginine</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Biology</subject><subject>endothelial function</subject><subject>erectile dysfunction</subject><subject>Erectile Dysfunction - metabolism</subject><subject>Erectile Dysfunction - pathology</subject><subject>Erectile Dysfunction - prevention & control</subject><subject>Humans</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Hypolipidemic Agents - therapeutic use</subject><subject>Internal Medicine</subject><subject>Laboratory Medicine</subject><subject>Male</subject><subject>metabolic syndrome</subject><subject>Metabolic Syndrome - drug therapy</subject><subject>Metabolic Syndrome - metabolism</subject><subject>Metabolic Syndrome - physiopathology</subject><subject>Middle Aged</subject><subject>Pathology</subject><subject>Ultralow Doses</subject><issn>0007-4888</issn><issn>1573-8221</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kUtLxTAQhYMoen38ADdaXOiqOpO0SbMU36AoqOuQ5iZa6W2uSYvcf28u9QEuXM0M-c4ZMoeQXYRjBBAnEaFEkQPIHLiEHFbIBEvB8opSXCUTSFBeVFW1QTZjfFuOwHGdbFAAKlhZTcjNQ_Dz10WrTd-YmHmXXQSb-tZm54vohi71vsuaLnvQfWO7PmYfTf-a3dle175tTPa46KbBz-w2WXO6jXbnq26R58uLp7Pr_Pb-6ubs9DY3TIg-l8gdNzWjWjjJjaVTVkswWlrUJdICOOUUjbMFTrWQgqFwgKyusOasQMG2yNHoOw_-fbCxV7MmGtu2urN-iEowJoAVZZHIw39JirTiheQJPPgDvvkhdOkXiWGFLKWkCcIRMsHHGKxT89DMdFgoBLWMQ41xqBSHWsahIGn2voyHemanP4rv-yeAjkBMT92LDb-b_3PdH0VOe6VfQhPV8yNNRwIUWDJZsk-UKZyI</recordid><startdate>20090801</startdate><enddate>20090801</enddate><creator>Gamidov, S. I</creator><creator>Mazo, E. B</creator><creator>Gasanov, R. V</creator><creator>Sotnikova, E. M</creator><general>Boston : Springer US</general><general>Springer US</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20090801</creationdate><title>Prophylactics of Erectile Dysfunction in Patients with Metabolic Syndrome</title><author>Gamidov, S. I ; Mazo, E. B ; Gasanov, R. V ; Sotnikova, E. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c377t-916f6cb32a7f96ce2d3b90ca9e1a5124062621cfe41da797317f013b81b634173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antibodies - therapeutic use</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Arginine - analogs & derivatives</topic><topic>Arginine - metabolism</topic><topic>asymmetrical dimethylarginine</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Biology</topic><topic>endothelial function</topic><topic>erectile dysfunction</topic><topic>Erectile Dysfunction - metabolism</topic><topic>Erectile Dysfunction - pathology</topic><topic>Erectile Dysfunction - prevention & control</topic><topic>Humans</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Hypolipidemic Agents - therapeutic use</topic><topic>Internal Medicine</topic><topic>Laboratory Medicine</topic><topic>Male</topic><topic>metabolic syndrome</topic><topic>Metabolic Syndrome - drug therapy</topic><topic>Metabolic Syndrome - metabolism</topic><topic>Metabolic Syndrome - physiopathology</topic><topic>Middle Aged</topic><topic>Pathology</topic><topic>Ultralow Doses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gamidov, S. I</creatorcontrib><creatorcontrib>Mazo, E. B</creatorcontrib><creatorcontrib>Gasanov, R. V</creatorcontrib><creatorcontrib>Sotnikova, E. M</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Bulletin of experimental biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gamidov, S. I</au><au>Mazo, E. B</au><au>Gasanov, R. V</au><au>Sotnikova, E. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prophylactics of Erectile Dysfunction in Patients with Metabolic Syndrome</atitle><jtitle>Bulletin of experimental biology and medicine</jtitle><stitle>Bull Exp Biol Med</stitle><addtitle>Bull Exp Biol Med</addtitle><date>2009-08-01</date><risdate>2009</risdate><volume>148</volume><issue>2</issue><spage>318</spage><epage>321</epage><pages>318-321</pages><issn>0007-4888</issn><eissn>1573-8221</eissn><coden>BEXBAN</coden><abstract>For prophylactics of erectile dysfunction in patients with metabolic syndrome, all unfavorable life-style factors should be excluded and all metabolic disturbances should be corrected. This will reduce the severity and stabilize the course of metabolic syndrome. Administration of special drugs is required for prevention of erection disturbances.</abstract><cop>Boston</cop><pub>Boston : Springer US</pub><pmid>20027358</pmid><doi>10.1007/s10517-009-0690-0</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-4888 |
| ispartof | Bulletin of experimental biology and medicine, 2009-08, Vol.148 (2), p.318-321 |
| issn | 0007-4888 1573-8221 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_733703454 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Adult Aged Antibodies - therapeutic use Antihypertensive Agents - therapeutic use Arginine - analogs & derivatives Arginine - metabolism asymmetrical dimethylarginine Biomedical and Life Sciences Biomedicine Cell Biology endothelial function erectile dysfunction Erectile Dysfunction - metabolism Erectile Dysfunction - pathology Erectile Dysfunction - prevention & control Humans Hypoglycemic Agents - therapeutic use Hypolipidemic Agents - therapeutic use Internal Medicine Laboratory Medicine Male metabolic syndrome Metabolic Syndrome - drug therapy Metabolic Syndrome - metabolism Metabolic Syndrome - physiopathology Middle Aged Pathology Ultralow Doses |
| title | Prophylactics of Erectile Dysfunction in Patients with Metabolic Syndrome |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T04%3A22%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prophylactics%20of%20Erectile%20Dysfunction%20in%20Patients%20with%20Metabolic%20Syndrome&rft.jtitle=Bulletin%20of%20experimental%20biology%20and%20medicine&rft.au=Gamidov,%20S.%20I&rft.date=2009-08-01&rft.volume=148&rft.issue=2&rft.spage=318&rft.epage=321&rft.pages=318-321&rft.issn=0007-4888&rft.eissn=1573-8221&rft.coden=BEXBAN&rft_id=info:doi/10.1007/s10517-009-0690-0&rft_dat=%3Cproquest_cross%3E1921532081%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=213495992&rft_id=info:pmid/20027358&rfr_iscdi=true |